Multiple sclerosis and COVID vaccination: how to improve the response by erasing B cells
Medicomunicare Magazine | Health and Medical News
New research shows that Multiple Sclerosis (MS) patients undergoing anti-CD20 (aCD20) treatment – which depletes the B cells that contribute to the MS attacks – are able to mount robust T-cell responses to the mRNA COVID-19 vaccines, despite having a muted antibody response to the vaccines. Because B cells are responsible for antibody production, patients’